Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2025 ,inter alia, to consider and approve Pursuant to Régulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories has informed BSE that its Board of Directors will meet on Thursday, September 25, 2025, at the company's registered office in Ghatkopar, Mumbai. The main item on the agenda is to approve the Cost Audit Report in Form CRA-3 for the financial year 2024-2025. The notice was filed under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29(1)). The filing was signed by the Company Secretary, Dhwani Desai, on September 20, 2025. A standard 'any other business with the permission of the chairman' clause is also included.
This is a routine regulatory compliance filing with no indication of any major corporate action like results, dividend, or fundraising on the agenda. Shareholders are unlikely to see any meaningful stock price movement from this notice.